Sanofi to acquire transplant therapies provider Kadmon for $1.9bn

By NS Healthcare Staff Writer

09 Sep 21

The acquisition will add Rezurock, an FDA-approved treatment for chronic graft-versus-host disease (cGVHD), to Sanofi’s transplant portfolio

Patient CarePharmaceuticals and Medicines

Novo Nordisk to buy Prothena’s ATTR amyloidosis business

By NS Healthcare Staff Writer

13 Jul 21

Novo Nordisk intends to initially develop the Phase 2 ready antibody PRX004 for the rare heart disease ATTR…

Patient CarePharmaceuticals and Medicines

Perrigo closes sale of Generic Rx business for $1.55bn

By NS Healthcare Staff Writer

07 Jul 21

With the divestiture of Generic Rx Pharmaceutical business, Perrigo will become a pure-play global consumer self-care company

Patient CarePharmaceuticals and Medicines

Philip Morris to acquire Fertin Pharma in $820m deal

By NS Healthcare Staff Writer

02 Jul 21

The acquisition of Fertin Pharma would support PMI’s goal of generating more than 50% revenues from smoke-free products…

Patient CarePharmaceuticals and Medicines

Hologic to acquire molecular diagnostics firm Mobidiag for $795m

By NS Healthcare Staff Writer

09 Apr 21

The acquisition of Mobidiag will strengthen Hologic’s international and diagnostics businesses

Patient CareImaging, Diagnostics and Analysis

Roche to acquire molecular diagnostics firm GenMark for $1.8bn

By NS Healthcare Staff Writer

16 Mar 21

GenMark offers Respiratory Pathogen Panels that identify the most common viral and bacterial organisms related to upper respiratory…

Patient CareImaging, Diagnostics and Analysis

Cardinal Health to divest Cordis business to H&F for $1bn

By NS Healthcare Staff Writer

15 Mar 21

Cardinal Health expects that the sale of the Cordis business will decrease Medical segment profit by about $60m…

Patient CareCardiovascular

Boston Scientific to acquire cardiac health solutions provider Preventice

By NS Healthcare Staff Writer

22 Jan 21

The acquisition of Preventice will provide Boston Scientific with a foothold in the high-growth ambulatory electrocardiography space

Patient CareCardiovascular

Thermo Fisher to buy molecular diagnostics firm Mesa Biotech for $450m

By NS Healthcare Staff Writer

20 Jan 21

Thermo Fisher will additionally pay up to $100m in cash, after reaching certain milestones post-closing of the transaction

Patient CareImaging, Diagnostics and Analysis

Hologic to acquire molecular diagnostics firm Biotheranostics for $230m

By NS Healthcare Staff Writer

06 Jan 21

The acquisition of Biotheranostics will allow Hologic to leverage commercial capabilities and expertise in molecular diagnostics automation

Patient CareImaging, Diagnostics and Analysis